What are the benefits of administering DSIP through a nasal spray
For patients using these medications to manage obesity including those who had pre-diabetes, metabolic syndrome, or significant cardiovascular risk that restriction can feel deeply unfair, particularly if the medication was working
Newer drugs, such as tirzepatide, a dual GLP-1, and GIP receptor agonist, are quickly gaining traction and demonstrating encouraging outcomes in clinical trials for weight management. Other popular diabetes medications include metformin, gliflozins (Farxiga, Jardiance), and sulfonylureas (Glucotrol, Amaryl)
After 4 weeks, the dose should be increased to 0.5 mg once weekly, with further increases to 1 mg or 2 mg weekly if needed for glycaemic control
It's sealed in a sterile, stable environment